BiolineRx
About:
BioLineRx is a late clinical-stage biopharmaceutical development company that focuses on oncology.
Website: http://biolinerx.com
Top Investors: BlackRock, OrbiMed, Novartis, Teva Pharmaceuticals, Biotechnology Value Fund
Description:
BioLineRx is a clinical-stage, publicly traded (NASDAQ/ TASE: BLRX) biopharmaceutical development company based in Jerusalem, Israel. The Company develops products suitable for the pharmaceutical market satisfying an unmet medical need or exhibiting advantages over current therapies.
Total Funding Amount:
$277M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Jerusalem, Yerushalayim, Israel
Founded Date:
2003-01-01
Contact Email:
info(AT)BioLineRx.com
Founders:
Morris Laster
Number of Employees:
51-100
Last Funding Date:
2024-11-21
IPO Status:
Public
Industries:
© 2025 bioDAO.ai